Jilin Heart Hospital was established on October 18, 2004, as a tertiary-level specialized cardiac hospital. It covers a construction area of 29,000 square meters and has over 300 open beds. The hospital brings together outstanding cardiovascular disease diagnosis and treatment experts from both domestic and international backgrounds, capable of performing various cardiac medical and surgical procedures with proficiency.
Among its departments, the Cardiac Surgery Department has pioneered over twenty types of surgeries that have reached internationally advanced levels. The Cardiology Department performs over 5,000 cardiovascular interventional examinations and surgeries annually. In 2011, the Cardiology Department of Jilin Heart Hospital was approved as a "National Clinical Key Specialty Construction Project."
Jilin Heart Hospital consistently adheres to and implements the "Clinical Diagnosis and Treatment Guidelines" issued by the World Health Organization (WHO), Europe, the United States, and China. It actively promotes the National Health Commission's single-disease payment system and clinical pathway management, having already implemented clinical pathways for 78 diseases. Among these, 78 diseases are subject to fixed-rate charging (patients do not pay for any excess beyond the fixed rate). Currently, the hospital's drug expenditure ratio is 2.8%, and its Case Mix Index (CMI) is 4.02 (which can be regarded as a difficulty coefficient; the national average for hospitals of the same level is less than 1.5). The average charging level at the hospital is 20–40% lower than provincial-level rates for similar diseases. These measures have contributed to an overall reduction in cardiac surgery costs across the province. These diseases are now included in the DRG payment management system under medical insurance. The dual control of fixed-rate charging and DRG, along with the implementation of clinical pathways, ensures both service quality and cost control for patients while improving hospital service efficiency and promoting rational development. The implementation of these measures has effectively alleviated the financial burden on patients.
Jilin Heart Hospital maintains ongoing exchanges and collaborations with top-tier cardiac diagnosis and treatment institutions both domestically and internationally, working together to cultivate outstanding talent in the field of cardiovascular diseases.
To provide excellent services for the patients with Cardiac disease
To establish a regional heart center with the integration of health care, education and scientific research compliance with the international standards, which makes both the patients’ and employees’ needs satisfied!








| Honors and Awards | ||
|---|---|---|
| National Top 100 Credible Private Hospitals | National Most Valuable Private Hospital Award | National Credible Private Hospital |
| National Clinical Key Specialty Hospital | Training Base for Interventional Therapy of Complex Coronary Artery Disease | Jilin Provincial Social Organization Assessment: AAAAA |
| Third Grade Class A Cardiovascular Hospital | Jilin Charity Award - "Most Compassionate Charitable Donation Enterprise" | Pandemic Response Pioneer - Outstanding Contribution Unit in Group Blood Donation |
| Changchun Outstanding Contribution Enterprise in Non-Public Sector | Changchun Advanced Private (Social) Medical Institution (2007 & 2008) | Group Membership Unit in Co-construction Work (2011) |
| Safe Unit Award (2012) | Changchun Excellent Non-Public (Social) Medical Institution (2012) | Advanced Unit in Spiritual Civilization and Professional Ethics (2012) |
| Special Outstanding Contribution Award in Group Blood Donation (2018) | Advanced Unit Award in Group Blood Donation (2019) | Advanced Unit Award in Group Blood Donation (2022) |